Litman Gregory Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Litman Gregory Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$121K	Buy	+208	New	+$118K	0.01%	174

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Litman Gregory Wealth Management's TMO Position: Q4 2025 in Review

Litman Gregory Wealth Management opened a new position in Thermo Fisher Scientific (TMO) in Q4 2025: 208 shares worth $121K. The stake represents 0.01% of the portfolio and ranks #174 among its holdings.

2,710 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Litman Gregory Wealth Management held 208 shares of Thermo Fisher Scientific worth $121K as of Q4 2025.
Thermo Fisher Scientific was a new Litman Gregory Wealth Management position in Q4 2025.
Thermo Fisher Scientific made up 0.01% of Litman Gregory Wealth Management's portfolio in Q4 2025, its #174 holding.
2,710 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Litman Gregory Wealth Management's 13F filing for Q4 2025, filed 12 Feb 2026.